IGNE OTC
Igene Biotechnology, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -90.0%
5Y: -95.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$5M
-21.5% ▼
5Y CAGR: +8.2%
Total Liabilities
$8M
-14.2% ▼
5Y CAGR: -15.1%
Shareholders Equity
-$3M
-2.4% ▼
Cash & Investments
$1M
-13.0% ▼
5Y CAGR: +21.1%
Total Debt
$7M
+27.0% ▲
5Y CAGR: -9.4%
Net Debt
$6M
+42.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2003 | FY2006 | FY2007 | FY2008 | FY2009 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $63K | $22K | $1M | $1M | $1M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $63K | $22K | $1M | $1M | $1M |
| Net Receivables | $156K | $0 | $3M | $1M | $2M |
| Inventory | $44K | $0 | $8M | $2M | $0 |
| Other Current Assets | $495K | $0 | $0 | $0 | $0 |
| Total Current Assets | $758K | $36K | $12M | $5M | $4M |
| Property, Plant & Equip. | $149K | $34K | $713K | $832K | $853K |
| Goodwill & Intangibles | $0 | $0 | $150K | $150K | $150K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $12M | $5K | $393K | $128K | $98K |
| Total Non-Current Assets | $12M | $39K | $1M | $1M | $1M |
| Total Assets | $12M | $75K | $13M | $6M | $5M |
| — Liabilities — | |||||
| Accounts Payable | $186K | $210K | $0 | $0 | $0 |
| Short-Term Debt | $0 | $705K | $0 | $0 | $1M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $1K | $0 | $8M | $3M | $465K |
| Total Current Liabilities | $187K | $962K | $8M | $3M | $2M |
| Long-Term Debt | $11M | $15M | $19M | $5M | $6M |
| Other Non-Current Liab. | $6M | $219K | $226K | $541K | $240K |
| Total Non-Current Liabilities | $16M | $16M | $20M | $6M | $6M |
| Total Liabilities | $16M | $16M | $27M | $9M | $8M |
| — Equity — | |||||
| Common Stock | $927K | $1M | $1M | $15M | $16M |
| Retained Earnings | -$39M | -$43M | -$49M | -$53M | -$53M |
| Accumulated OCI | $0 | $0 | $0 | -$18K | $58K |
| Total Stockholders Equity | -$4M | -$16M | -$14M | -$3M | -$3M |
| Total Liabilities & Equity | $12M | $75K | $13M | $6M | $5M |
| — Key Metrics — | |||||
| Total Debt | $11M | $16M | $19M | $5M | $7M |
| Net Debt | $11M | $16M | $18M | $4M | $6M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |